Overview

The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia

Status:
Terminated
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine whether subjects with negative symptoms of schizophrenia have abnormal functioning of brain circuits relevant to reward processing, and to determine whether any such abnormalities are normalized by treatment with aripiprazole.
Phase:
N/A
Details
Lead Sponsor:
Emory University
Collaborator:
Bristol-Myers Squibb
Treatments:
Aripiprazole